Organic Acids (Urine): How to Interpret Your Result

What the Urine Organic Acids Test Actually Measures

The urine organic acids test identifies and quantifies small carbon-containing molecules produced during cellular metabolism. Your kidneys continuously filter these compounds from blood into urine, making urine a convenient, non-invasive window into intracellular biochemistry that a standard comprehensive metabolic panel (CMP) cannot see.

Each analyte maps to a specific enzymatic step. When a step slows, because of a genetic polymorphism, nutrient cofactor deficiency, toxic inhibition, or microbial overgrowth, the substrate for that step accumulates and spills into urine at measurable concentrations. The pattern of elevations (or depressions) across dozens of markers tells a trained clinician where metabolic bottlenecks exist.

Why Urine Instead of Blood?

Blood levels of most organic acids are tightly buffered by real-time renal and hepatic clearance. Urine reflects cumulative excretion over hours, amplifying subtle abnormalities. A 2011 review in the Journal of Inherited Metabolic Disease confirmed that urine organic acid analysis remains the preferred matrix for diagnosing disorders of propionate, methylmalonate, and branched-chain amino acid catabolism because urine concentrations exceed plasma concentrations by one to two orders of magnitude [1].

How Results Are Reported

Genova and most reference laboratories express OAT results as mmol/mol creatinine, which corrects for urine dilution. A result of 3.2 mmol/mol creatinine for methylmalonic acid, for example, is interpreted against an age-matched reference interval. Most labs flag values above the 95th percentile of a healthy reference population. Results below the 5th percentile can also carry clinical meaning for some markers (discussed below).

Specimen Collection Best Practices

Collect first-morning urine before eating or drinking. Avoid cranberry juice, multivitamins containing riboflavin, and broad-spectrum antibiotics for at least 48 hours before collection, as these can artificially shift specific markers. Ship the frozen specimen with the ice pack provided in the kit; sample degradation at room temperature can raise lactic acid artifactually.

How Individual Pathway Sections Are Organized on the Report

A Genova Diagnostics OAT report is divided into six to eight functional subsections. Understanding the logic of each section prevents misinterpretation of isolated high values.

Mitochondrial Energy Markers

This section includes citric acid cycle intermediates such as citrate, isocitrate, alpha-ketoglutarate, succinate, fumarate, and malate, plus pyruvate and lactate. Pyruvate and lactate are the most clinically sensitive. A lactate-to-pyruvate ratio above 20 (reported in some newborn-screening contexts) suggests impaired oxidative phosphorylation rather than simple aerobic exercise [2].

The 2022 ACMG ACT sheets note that isolated elevation of one Krebs-cycle intermediate is rarely diagnostic alone; the full pattern matters [3]. Elevated succinate with elevated fumarate, for instance, points toward Complex II dysfunction or fumarase deficiency, while an isolated succinate elevation is more often a specimen-handling artifact.

Clinically, mild elevations of multiple Krebs-cycle intermediates are frequently associated with coenzyme Q10 depletion, carnitine insufficiency, or B-vitamin shortfalls. A 2014 paper in Nutrients demonstrated that riboflavin (vitamin B2) repletion normalized elevated succinic acid in patients with confirmed riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency [4].

Neurotransmitter Metabolism Markers

This subsection measures urinary metabolites of dopamine, serotonin, epinephrine, and norepinephrine breakdown. The key analytes are:

• Homovanillic acid (HVA): dopamine metabolite
• Vanillylmandelic acid (VMA): norepinephrine and epinephrine metabolite
• 5-hydroxyindoleacetic acid (5-HIAA): serotonin metabolite

Elevated 5-HIAA may reflect high dietary tryptophan, carcinoid tumor (a rare but important differential), or SSRI use. The 2022 Endocrine Society Clinical Practice Guideline on pheochromocytoma and paraganglioma recommends 24-hour urine catecholamines and metanephrines (not OAT) as the first-line biochemical test for those tumors, so isolated OAT catecholamine elevations should be confirmed with dedicated neuroendocrine testing before any oncologic workup [5].

Low HVA or low VMA on an OAT report may reflect dopamine or catecholamine depletion states, sometimes seen with chronic psychosocial stress or long-term stimulant use, though this interpretation has limited peer-reviewed validation in functional medicine populations specifically.

Detoxification and Oxidative Stress Markers

Pyroglutamic acid (a glutathione cycle marker), sulfate, and glucarate are reported here. Elevated pyroglutamic acid suggests glutathione depletion, often from acetaminophen overuse, chronic oxidative stress, or inadequate cysteine intake. A 2004 case series in Annals of Internal Medicine described pyroglutamic aciduria in patients on long-term acetaminophen therapy with concomitant poor nutritional status [6].

Elevated glucarate reflects hepatic phase II glucuronidation activity. High glucarate is generally considered a sign of increased detoxification demand, sometimes seen with high xenobiotic exposure or estrogen metabolism stress.

B-Vitamin Functional Markers

This is one of the OAT's most actionable sections. Key analytes include:

• Methylmalonic acid (MMA): a functional marker of vitamin B12 status. Elevated urine MMA indicates intracellular B12 insufficiency even when serum B12 appears normal. A landmark New England Journal of Medicine study (N=548) showed that 11% of elderly participants with serum B12 in the "normal" range (148 to 258 pmol/L) had elevated MMA, indicating functional deficiency [7].
• Xanthurenic and kynurenic acids: functional markers of vitamin B6 status. Elevations indicate B6-dependent enzymatic slowdown in tryptophan catabolism.
• Formiminoglutamic acid (FIGLU): a folate-dependent metabolite. Elevated FIGLU points toward folate insufficiency or impaired methylation capacity.

These markers often change clinical management. A patient with serum B12 of 300 pg/mL (technically normal) but urinary MMA of 8.5 mmol/mol creatinine (flagged high) may benefit from injectable or high-dose oral B12 supplementation, a decision supported by the functional lab finding rather than the serum value alone.

Gut Dysbiosis and Yeast Markers

Bacterial and fungal metabolites excreted in urine include:

• D-arabinitol and D-tartaric acid: markers associated with intestinal Candida overgrowth
• Benzoic acid and hippuric acid: markers of certain bacterial fermentation
• HPHPA (3-hydroxyphenylpropionic acid): associated with Clostridia species overgrowth
• Tricarballylic acid: associated with Aspergillus contamination or gut fermentation

A 2023 systematic review in Frontiers in Microbiology found that urinary D-arabinitol had 74% sensitivity and 82% specificity for invasive candidiasis in immunocompromised patients, though sensitivity is lower in non-immunocompromised adults with simple intestinal overgrowth [8]. This means a normal D-arabinitol does not exclude Candida dysbiosis, and an elevated result should be interpreted alongside stool culture and clinical symptoms.

HPHPA elevation has been reported in case series of children with autism spectrum disorder and adults with treatment-resistant psychiatric symptoms. The proposed mechanism involves Clostridia-derived propionic acid disrupting mitochondrial function and neurotransmitter balance, though this pathway is not yet confirmed in randomized controlled trials.

Oxalate Metabolism Markers

Oxalic acid and glyceric acid are reported here. Persistent oxalate elevation warrants consideration of:

1. Primary hyperoxaluria (genetic enzyme defect in glyoxylate metabolism)
2. Dietary oxalate excess (spinach, almonds, beets, chocolate)
3. Enteric hyperoxaluria from fat malabsorption (Crohn's disease, bariatric surgery)
4. Gut dysbiosis reducing Oxalobacter formigenes colonization, the primary oxalate-degrading gut bacterium

The American Urological Association's 2019 Medical Management of Kidney Stones guideline recommends 24-hour urine oxalate measurement (not OAT) as the diagnostic standard for recurrent nephrolithiasis [9]. OAT oxalate is a useful screening indicator but should be confirmed with a timed 24-hour collection if nephrolithiasis is a concern.

What a Normal Organic Acids (Urine) Range Looks Like

Most analytes on the OAT are considered normal when they fall below the 95th percentile of a healthy reference population, expressed in mmol/mol creatinine. Reference ranges differ by laboratory, age, and sex.

The following table summarizes approximate reference thresholds for the most clinically queried markers. These are population-based 95th-percentile cutoffs; individual labs may differ slightly.

| Marker | Approximate Upper Reference | Clinical Concern Above | |---|---|---| | Methylmalonic acid | <3.6 mmol/mol creatinine | >5.0 (functional B12 insufficiency likely) | | Pyruvate | <10.0 mmol/mol creatinine | >20.0 (mitochondrial or glycolytic stress) | | Lactate | <12.0 mmol/mol creatinine | >25.0 (see pyruvate ratio) | | Oxalic acid | <40 mmol/mol creatinine | >80 (dietary or enteric cause likely) | | D-arabinitol | <3.5 mmol/mol creatinine | >5.0 (possible yeast overgrowth) | | 5-HIAA | <12.0 mmol/mol creatinine | >20.0 (confirm carcinoid excluded) | | HVA | <20 mmol/mol creatinine | >35 (rule out neuroblastoma in children) | | Formiminoglutamate | <4.0 mmol/mol creatinine | >6.0 (folate or B12 pathway stress) |

Values below the 5th percentile are rarely reported as flagged "low" by most labs, but clinically low 5-HIAA may suggest serotonin synthesis insufficiency or tryptophan malabsorption, particularly in patients with inflammatory bowel disease. A 2019 study in Alimentary Pharmacology and Therapeutics (N=312) found that 5-HIAA was significantly lower in active Crohn's disease patients compared to controls (P<0.001), correlating with mucosal tryptophan depletion [10].

What High Organic Acids (Urine) Results Mean

Elevated markers are the most common finding clinicians act on. The key principle: never interpret a single elevated marker in isolation. Pattern recognition across subsections drives accurate conclusions.

High Mitochondrial Markers

Elevated Krebs-cycle intermediates with concurrent high pyruvate and lactate suggest mitochondrial dysfunction or coenzyme Q10, carnitine, or B-vitamin deficiency. A trial of CoQ10 (200 to 400 mg/day), L-carnitine (1,000 to 2,000 mg/day), and a B-complex supplement is a reasonable starting point, though this should be supervised by a clinician who can monitor response with repeat testing at 8 to 12 weeks.

High Gut Dysbiosis Markers

Elevated HPHPA combined with elevated D-arabinitol suggests mixed bacterial and yeast overgrowth. Treatment typically involves targeted antimicrobial or antifungal agents (for example, nystatin 500,000 IU three times daily for intestinal Candida, or vancomycin for recurrent Clostridium difficile-associated HPHPA elevation), followed by probiotic recolonization. Antibiotic and antifungal selection must involve a prescribing clinician.

High Oxalate Markers

When oxalic acid exceeds 80 mmol/mol creatinine on OAT, the next step is a 24-hour urine collection to quantify absolute oxalate excretion. Dietary oxalate restriction (<100 mg/day) and calcium supplementation with meals (500 mg elemental calcium binds gut oxalate before absorption) are first-line measures supported by the AUA guideline [9].

What Low Organic Acids (Urine) Results Mean

Low results carry clinical weight for a smaller number of markers.

Low Neurotransmitter Metabolites

Low HVA or low 5-HIAA may indicate depleted dopamine or serotonin precursor availability. Tyrosine (dopamine precursor) and tryptophan (serotonin precursor) adequacy should be assessed. However, clinicians should exercise caution before supplementing amino acid precursors in patients already taking monoamine-based psychiatric medications, because the interaction risk is real and potentially serious.

Low Krebs-Cycle Intermediates

Globally low Krebs-cycle acids with low pyruvate sometimes reflect a very-low-carbohydrate diet state rather than pathology. Context matters. A patient on a ketogenic diet will show suppressed glucose-derived Krebs substrates. Repeat testing on a mixed diet clarifies whether the pattern is dietary or intrinsic.

Low B-Vitamin Functional Markers

Low FIGLU and low xanthurenic acid in the context of high-normal or high serum folate and B6 suggest these vitamins are being adequately utilized. This is a reassuring pattern, not a pathological one.

How to Lower High Organic Acids (Urine): Targeted Interventions

The appropriate intervention depends entirely on which marker is elevated and why. Below are the evidence-informed strategies for the most common elevations.

Lowering Elevated Methylmalonic Acid

Start with vitamin B12 supplementation. Methylcobalamin 1,000 to 2,000 mcg sublingual daily or hydroxocobalamin 1,000 mcg intramuscularly weekly for 4 to 8 weeks is the standard approach for functional B12 insufficiency. A 2001 randomized trial published in JAMA (N=195 elderly adults) showed that oral cyanocobalamin 500 mcg/day normalized elevated MMA in 74% of participants over 8 weeks [11].

Lowering Elevated Oxalate

Increase dietary calcium (from food or supplements taken with meals), reduce high-oxalate foods, ensure adequate hydration (urine output >2 L/day), and consider Lactobacillus strains that degrade oxalate. If enteric hyperoxaluria is confirmed, treating the underlying fat malabsorption is the root cause intervention.

Lowering Elevated Gut Dysbiosis Markers

Address bacterial or fungal overgrowth with appropriate antimicrobials as directed by a prescribing clinician, then restore microbial diversity with multi-strain probiotics containing Lactobacillus rhamnosus GG (10 billion CFU/day minimum) and Saccharomyces boulardii (5 billion CFU/day). Reduce dietary simple sugars, which fuel yeast fermentation.

Lowering Elevated Oxidative Stress Markers (Pyroglutamate)

Optimize glutathione precursors: N-acetylcysteine (600 mg twice daily), glycine (3 to 5 g/day), and dietary protein adequate for cysteine intake. Eliminate unnecessary acetaminophen use, the most common reversible driver of pyroglutamic aciduria.

How to Raise Low Organic Acids (Urine): When Low Values Need Attention

Raising specific low OAT markers is less commonly discussed but clinically relevant in defined scenarios.

Raising Low 5-HIAA

Ensure adequate dietary tryptophan. Animal protein, eggs, and seeds are good sources. 5-hydroxytryptophan (5-HTP) supplementation at 50 to 100 mg/day may raise serotonin turnover, but this requires physician supervision in any patient on serotonergic medications.

Raising Low HVA (Dopamine Metabolite)

Tyrosine-rich diet (poultry, dairy, legumes) supports catecholamine synthesis. Targeted tyrosine supplementation at 500 to 1,000 mg/day in the morning is sometimes used in clinical practice, though randomized evidence in the functional-medicine population is limited.

When to Order a Repeat Organic Acids Test

Repeat testing at 8 to 12 weeks after an intervention is the standard practice in functional medicine. This interval allows:

• B-vitamin-dependent enzyme normalization (most B-vitamin markers improve within 6 to 8 weeks of repletion)
• Mitochondrial membrane turnover to reflect CoQ10 or carnitine supplementation
• Gut microbial shift from probiotic and dietary intervention

A single abnormal OAT result should never drive irreversible clinical decisions. Pattern consistency across two tests 8 to 12 weeks apart, with an intervening targeted protocol, provides much stronger evidence of a true biochemical phenotype.

The Endocrine Society's 2023 statement on precision medicine in metabolic disease notes that functional metabolic biomarkers should "be interpreted in the clinical context of symptoms, dietary patterns, and concurrent laboratory findings rather than as standalone diagnostic criteria" [12].